Company Analysis

ImageneBio, Inc. (IMA)

Nasdaq: IMA · Biological Products, (No Diagnostic Substances) · San Diego, CA · filing with the SEC since 2021
Grade3.6
◀ Past 5.0● Present 2.6▶ Future 3.7
2 est.

Who runs ImageneBio, Inc.

Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filed
Chief executive, as filed
Yarema Kristin
Chief Executive Officer. First filing Jul 2025, latest Aug 17, 2026, 0 filings in all.
Officers reporting now
7
of 16 people with a filing in the last fifteen months
Directors reporting now
9
30 people on the record since 2021
Officerssales are open-market, Sep 30, 2025 to Sep 30, 2026
NameTitle as filedFirst filingLatest filingSales, 12 months
Yarema KristinChief Executive OfficerJul 2025Aug 17, 2026none
Grant-Huerta YaninaChief Financial OfficerJul 2026Aug 17, 2026none
Lally Robert BPrincipal Accounting OfficerApr 2026Jul 20, 20262 · $0.00
Porter-Brown BenjaminChief Medical OfficerFeb 2026Feb 20, 2026none
Butler ErinPrincipal Accounting OfficerJul 2025Jan 2, 2026none
Lu YufangChief Medical OfficerAug 2025Aug 7, 2025none
Marango JotinChief Financial OfficerApr 2022Jul 29, 2025none
Directorssales are open-market, Sep 30, 2025 to Sep 30, 2026
NameRoleFirst filingLatest filingSales, 12 months
Bonita David PdirectorMar 2021Jun 18, 2026none
Slattery Joseph PdirectorNov 2025Jun 18, 2026none
Stampacchia OtellodirectorMar 2021Jun 18, 2026none
Wang Jonathan JiandirectorJul 2025Jun 18, 2026none
Orbimed Advisors LLCdirectorMar 2021Apr 16, 2026none
Orbimed Capital Gp Vi LLCdirectorMar 2021Apr 16, 2026none
Orbimed Genesis Gp LLCdirectorMar 2021Apr 16, 2026none
Su Wei-GuodirectorApr 2026Apr 16, 2026none
Wang Stephen HuidirectorJul 2025Dec 22, 2025none
Earlier names on the record23, newest filing first

A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.

SI Assistanton IMA · research, not advice